OrbiMed’s Monte Rosa Therapeutics GLUE Stock Holding History

OrbiMed’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$208K	Sell
2022 Q3	$960	Buy
2021 Q3	–	Sell
2021 Q2	$7.95M	Buy